These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10404879)

  • 21. Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals.
    Butler M
    Appl Microbiol Biotechnol; 2005 Aug; 68(3):283-91. PubMed ID: 15834715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Summary and conclusion. Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals.
    Castle P; Robertson JS
    Dev Biol Stand; 1999; 99():191-6. PubMed ID: 10404890
    [No Abstract]   [Full Text] [Related]  

  • 23. Bovine polyomavirus, a frequent contaminant of calf sera.
    van der Noordaa J; Sol CJ; Schuurman R
    Dev Biol Stand; 1999; 99():45-7. PubMed ID: 10404875
    [No Abstract]   [Full Text] [Related]  

  • 24. Detection of adventitious viruses in biologicals--a rare occurrence.
    Nims RW
    Dev Biol (Basel); 2006; 123():153-64; discussion 183-97. PubMed ID: 16566443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of serum-free media for cell growth and production of viruses/viral vaccines--safety issues of animal products used in serum-free media.
    Merten OW
    Dev Biol (Basel); 2002; 111():233-57. PubMed ID: 12678248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The development, benefits and disadvantages of serum-free media.
    Froud SJ
    Dev Biol Stand; 1999; 99():157-66. PubMed ID: 10404887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of seropositivity for bovine leukemia virus, bovine viral diarrhoea virus, Mycobacterium avium subspecies paratuberculosis, and Neospora caninum on culling in dairy cattle in four Canadian provinces.
    Tiwari A; VanLeeuwen JA; Dohoo IR; Stryhn H; Keefe GP; Haddad JP
    Vet Microbiol; 2005 Aug; 109(3-4):147-58. PubMed ID: 15970402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic analysis for the assessment of different lots of fetal bovine serum as a raw material for cell culture. Part IV. Application of proteomics to the manufacture of biological drugs.
    Zheng X; Baker H; Hancock WS; Fawaz F; McCaman M; Pungor E
    Biotechnol Prog; 2006; 22(5):1294-300. PubMed ID: 17022666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum supply: policies and controls operating in New Zealand.
    Shailer C; Corrin K
    Dev Biol Stand; 1999; 99():71-7. PubMed ID: 10404878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Goat serum: an alternative to fetal bovine serum in biomedical research.
    Paranjape S
    Indian J Exp Biol; 2004 Jan; 42(1):26-35. PubMed ID: 15274477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inspection of veterinary biologics in the United States.
    Randall DC
    Dev Biol Stand; 1992; 79():163-70. PubMed ID: 1286751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Collection of source material from remunerated donors.
    Rodell MB
    Dev Biol Stand; 1993; 81():57-64. PubMed ID: 8174821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sourcing pharmaceutical, biological and medical components from livestock in the United States.
    Detwiler LA
    Dev Biol Stand; 1996; 88():243-5. PubMed ID: 9119145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transfusion safety: Where are we today?
    Luban NL
    Ann N Y Acad Sci; 2005; 1054():325-41. PubMed ID: 16339681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presentation of the EEC directive (81/852)--quality.
    Lee AM
    Dev Biol Stand; 1992; 79():39-41. PubMed ID: 1286763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Contamination of bovine fetal serum with bovine viral diarrhea virus].
    Zabal O; Kobrak AL; Lager IA; Schudel AA; Weber EL
    Rev Argent Microbiol; 2000; 32(1):27-32. PubMed ID: 10785940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clearance of viruses and transmissible spongiform encephalopathy agents from biologicals.
    Farshid M; Taffs RE; Scott D; Asher DM; Brorson K
    Curr Opin Biotechnol; 2005 Oct; 16(5):561-7. PubMed ID: 16095899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of animal cell substrates for biological products.
    Petricciani J; Sheets R
    Biologicals; 2008 Nov; 36(6):359-62. PubMed ID: 18674929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection and traceability of genetically modified organisms in the food production chain.
    Miraglia M; Berdal KG; Brera C; Corbisier P; Holst-Jensen A; Kok EJ; Marvin HJ; Schimmel H; Rentsch J; van Rie JP; Zagon J
    Food Chem Toxicol; 2004 Jul; 42(7):1157-80. PubMed ID: 15123385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress of control and prevention programs for bovine viral diarrhea virus in Europe.
    Sandvik T
    Vet Clin North Am Food Anim Pract; 2004 Mar; 20(1):151-69. PubMed ID: 15062480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.